Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
UPDATE: Gladstone Land (LAND) PT Raised to $14 at Ladenburg Thalmann
-
Symic Bio to Present at the Ladenburg Thalmann 2017 Annual Healthcare Conference
-
KCAP Financial, Inc. Announces Public Offering of Additional 6.125% Notes Due 2022
-
CryoLife to Present at Two Investor Conferences in September 2017
-
Intra-Cellular Therapies to Participate at Upcoming Investor Conferences
-
Ignyta to Present at the Ladenburg Thalmann 2017 Healthcare Conference
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Wall Street hits record highs, S&P 500 pierces 2,500
-
Securities America Rolls out Industry's First Customizable Recruiting Kit
-
Trillium Therapeutics to Present at Investor and Scientific Conferences in September
-
Great Elm Capital Corp. Prices Public Offering of Approximately $28.4 Million of 6.50% Notes Due 2022
-
Alpine Immune Sciences to Present at Ladenburg Thalmann 2017 Healthcare Conference
-
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
-
Gladstone Land Corporation Announces Closing of Offering of 1,150,000 Shares of its Common Stock for Gross Proceeds of Approximately $14.1 Million
-
EnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare Conference
-
VBI Vaccines to Present at September 2017 Investor Conferences
-
Securities America Welcomes Benson Financial Group
-
TransEnterix to Participate in Two Upcoming Healthcare Conferences
-
Achillion Pharmaceuticals (ACHN) PT Lowered to $6.50 at Ladenburg Thalmann
-
MGM Growth Properties LLC Announces Closing Of Public Offering Of Class A Shares And Exercise Of Over-Allotment Option
-
UPDATE: Ladenburg Thalmann Upgrades EPR Properties (EPR) to Buy
-
UPDATE: Ladenburg Thalmann Upgrades National Retail Properties (NNN) to Buy
-
Gladstone Land (LAND) Prices 1M Shares at $12.25
-
Gladstone Land Corporation Announces Pricing of Common Stock Offering
-
Gladstone Land (LAND) Reports Common Share Offering
-
Cempra Announces Presentations at Upcoming Investor Conferences and Provides Merger Process Update
-
Gladstone Land Corporation Announces Common Stock Offering
-
Bellerophon Therapeutics to Provide Corporate Update at Two Investor Conferences
-
UPDATE: Independence Realty Trust (IRT) Drop Post Deal Not Warranted - Ladenburg Thalmann
-
Pre-Open Movers 09/07: (RH) (CAB) (GPRO) Higher; (NCS) (BKS) (ALNY) Lower (more...)
-
Ladenburg Thalmann Starts Yatra Online (YTRA) at Buy
-
Kamada to Present Corporate Overview at Two Investor Conferences in September
-
Independence Realty Trust (IRT) Announces 12.5M Share Common Offering at $9.25/Sh
-
MGM Growth Properties LLC Announces Pricing Of Public Offering Of Class A Shares
-
VolitionRx Limited to Attend Multiple Conferences in September
-
Triad Advisors Commences 20th Annual National Advisor Conference In La Jolla, California
-
Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences
-
aTyr Pharma to Present at Two Upcoming Investor Conferences in September
-
Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in September 2017
-
Investacorp Welcomes Financial Advisor David Charles Miller
-
OPKO Health to Present at Upcoming September Conferences
-
Kamada Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Kindred Biosciences to Present at Upcoming Investor Conferences
-
Ladenburg Thalmann Upgrades Intra-Cellular Therapies (ITCI) to Buy
-
Bellicum Pharmaceuticals to Present at Three Healthcare Investor Conferences in September
-
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
-
ADMA Biologics to Present at Upcoming Investor Conferences
-
Paratek Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
-
ChromaDex Announces Closing of Third and Final Tranche of the $25 Million Strategic Investment Led by Mr. Li Ka-shing and Appoints Two Additional Board Members
-
Shift from non-GAAP bottom lines could be good for stock prices

